Andrea Gombos
- Oncology top 5%
- HER2/EGFR in Cancer Research 15
- Cancer Treatment and Pharmacology 10
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 4
- Cancer Research top 10%
- Breast Cancer Treatment Studies 7
-
- Advanced Breast Cancer Therapies 10
-
- Chronic Lymphocytic Leukemia Research 5
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Ahmad AwadaMartine PiccartSofiya LatifyanCinzia SolinasLaurence BuisseretMarleen KokChris TwelvesMaria Jové
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)Cancer Research (5 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Andrea Gombos
40 papers receiving 790 citations
Peers
Comparison fields: 5 of 64
- Oncology 529
- Cancer Research 210
- Pulmonary and Respiratory Medicine 239
- Genetics 61
- Immunology 112
Countries citing papers authored by Andrea Gombos
This map shows the geographic impact of Andrea Gombos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Gombos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Gombos more than expected).
Fields of papers citing papers by Andrea Gombos
This network shows the impact of papers produced by Andrea Gombos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Gombos. The network helps show where Andrea Gombos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea Gombos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 48 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 8 | |
| 9 | 2020 | 5 | |
| 10 | 2019 | 76 | |
| 11 | Phase Ib/II study evaluating safety and efficacy of Pembrolizumab and Trastuzumab in patients with Trastuzumab-resistant HER2-positive advanced breast cancer : results from the PANACEA study (IBCSG 45-13/BIG 4-13/KEYNOTE-014) | 2017 | 5 |
| 12 | 2017 | 119 | |
| 13 | 2016 | 20 | |
| 14 | 2016 | 4 | |
| 15 | 2016 | 14 | |
| 16 | 2016 | 64 | |
| 17 | 2016 | 26 | |
| 18 | 2014 | 36 | |
| 19 | 2013 | 42 | |
| 20 | 2012 | 39 |
About Andrea Gombos
Andrea Gombos is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 805 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (15 papers), Advanced Breast Cancer Therapies (10 papers), Cancer Treatment and Pharmacology (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Breast Cancer Treatment Studies (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Oncology (529 citations), Cancer Research (210 citations) and Pulmonary and Respiratory Medicine (239 citations). Andrea Gombos has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Ahmad Awada, Martine Piccart, Sofiya Latifyan, Cinzia Solinas, Laurence Buisseret, Marleen Kok, Chris Twelves, Maria Jové, Philippe Aftimos and Lissandra Dal Lago. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.